サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515549

ゲノム検査市場：検査タイプ別、疾患別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Genome Testing Market, By Test Type, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 398 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ゲノム検査市場：検査タイプ別、疾患別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 398 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ゲノム検査市場規模は2023年に89億5,420万米ドルとなり、2024年から2032年にかけてCAGR 22.50%で拡大

ゲノム検査市場 - 市場力学

様々な用途におけるDNA検査ニーズの高まり

診断検査は、特定の遺伝子異常や染色体異常を特定または除外するために用いられます。身体的徴候や症状が問題を指し示している場合、診断を確定するために遺伝子検査が一般的に用いられます。診断検査は、すべての遺伝子や遺伝的状態について実施できるわけではありませんが、出生前又は個人の生涯のいつでも実施することができます。診断検査の結果は、医療や疾病管理に関する決定に影響を及ぼす可能性があります。DNA配列は、法的目的のために個人を識別するための法医学的検査に使用されます。この検査は、個人間の生物学的関係の確立、犯罪や悲劇の被害者の特定、犯罪容疑者の排除や関与の有無などに利用されます。

ゲノム検査市場 - 主な洞察

当社のリサーチアナリストは、世界市場は2024年から2032年にかけて約22.50%のCAGRで発展すると予測しています。

検査タイプ別では、診断検査分野が2023年に最大の収益シェアを占めました。

疾患別では、2023年にはがんが市場を独占します。

地域別では、2023年に北米が収益の主役となります。

ゲノム検査市場 - セグメンテーション分析：

世界のゲノム検査市場は、検査タイプ、疾患、地域に基づいてセグメント化されます。

市場は検査タイプに基づいて7つのカテゴリーに分類されます：キャリア検査、予測検査、診断検査、出生前・新生児検査、ニュートリゲノミクス、ファーマコゲノミクス、その他。診断検査分野は、2023年の収益で世界の遺伝子検査市場を独占し、予測期間中もその優位性を維持すると予想されます。これは単に、世界人口の慢性疾患の頻度が上昇しているためです。ある調査によると、米国の人口の60％近くが少なくとも1つの慢性疾患に苦しんでいます。さらに、高齢者人口の急増と高齢者の診断検査ニーズの高まりが、近年の同分野の拡大を後押ししています。

市場は疾患別に7つのカテゴリーに分類されます：がん、アルツハイマー病、サラセミア、嚢胞性線維症、ハンチントン病、デュシェンヌ型筋ジストロフィー、その他の疾患です。2023年には、がんカテゴリーが収益面で世界の遺伝子検査市場を独占し、予測期間中もその優位性を維持すると予想されます。これは単純に、世界人口におけるがんの有病率の上昇によるものです。乳がん、肺がん、腸がん、子宮がんなどの癌の有病率の上昇が、このカテゴリーの主な促進要因です。

ゲノム検査市場 - 地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに存在します。これらのゾーンは、どの国がビジネスをもたらすかに基づいてさらに分割されます。北米は2023年の収益で世界の遺伝子検査市場を独占しており、その支配は予測期間中も続くと予想されます。これは、一般集団における遺伝子検査の利点に関する消費者の知識の高まりによるものと考えられます。さらに、米国などの国々では、オンラインウェブサイトを通じて自己検査キットが広く利用できるようになったことで、国民の遺伝子検査キット利用が増加しています。さらに、人口の大多数における慢性疾患の有病率の上昇が、ヘルスケアに対する消費支出の増加と相まって、市場の拡大を加速させています。米国における高齢者人口の増加は、今後数年間の市場を牽引すると思われます。

アジア太平洋は、中国、インド、韓国、日本の膨大な対象人口により、最も急速に成長している市場です。さらに、市場拡大の主な促進要因の1つは、慢性疾患や感染症の迅速な検査と診断のために、DNAシーケンシングなどの最新の検査技術や手法の利用が拡大していることです。

ゲノム検査市場 - 競合情勢：

ゲノム検査市場の競合情勢では、複数の企業が高度なゲノム検査サービスや製品を提供するために競争しています。Genentech Inc.、Sorenson Genomics, LLC、Abbott Molecular、Bayer Diagnostics、およびBiocartisは、最先端のゲノム配列決定および解析技術を製造している大手企業です。これらの企業は、研究開発への投資、戦略的提携の構築、斬新な検査ソリューションの導入により、競争力の維持を目指しています。競合環境を理解することで、市場力学に関する有用な考察を得ることができ、企業はゲノム検査業界で十分な情報に基づいた意思決定を行うことができます。

目次

第1章 ゲノム検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ゲノム検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ゲノム検査産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ゲノム検査市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ゲノム検査市場情勢

  • ゲノム検査市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ゲノム検査市場：検査タイプ別

  • 概要
    • セグメントシェア分析
    • キャリア検査
    • 予測検査
    • 診断検査
    • 出生前検査と新生児検査
    • ニュートリゲノミクス
    • ファーマコゲノミクス
    • その他

第8章 ゲノム検査市場：疾患別

  • 概要
    • セグメントシェア分析
    • がん
    • アルツハイマー病
    • サラセミア
    • 嚢胞性線維症
    • ハンチントン病
    • デュシェンヌ型筋ジストロフィー
    • その他の病気

第9章 ゲノム検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：ゲノム検査業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Genentech Inc.
    • Sorenson Genomics, LLC
    • Abbott Molecular
    • Bayer Diagnostics
    • Biocartis
    • BioHelix
    • Celera Genomics
    • Genomic Health
    • HTG Molecular Diagnostics
    • PacBio
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genome Testing Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Genome Testing Market, by Test Type 2019-2032 (USD Million)
  • TABLE Genome Testing Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Genome Testing Market, by Disease 2019-2032 (USD Million)
  • TABLE TABLE Genome Testing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genome Testing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Disease, 2019-2032 (USD Million)

List of Figures

  • FIGURE Genome Testing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Test Type segment market share analysis, 2023 & 2032
  • FIGURE Test Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease segment market share analysis, 2023 & 2032
  • FIGURE Disease segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Genome Testing Market share and leading players, 2023
  • FIGURE Europe Genome Testing Market share and leading players, 2023
  • FIGURE Asia Pacific Genome Testing Market share and leading players, 2023
  • FIGURE Latin America Genome Testing Market share and leading players, 2023
  • FIGURE Middle East and Africa Genome Testing Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Genome Testing Market share analysis by country, 2023
  • FIGURE Germany Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Genome Testing Market share analysis by country, 2023
  • FIGURE India Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genome Testing Market share analysis by country, 2023
  • FIGURE Brazil Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genome Testing Market share analysis by country, 2023
  • FIGURE Saudi Arabia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3302

REPORT HIGHLIGHT

Genome Testing Market size was valued at USD 8,954.2 Million in 2023, expanding at a CAGR of 22.50% from 2024 to 2032.

DNA testing has several medical uses, including infant DNA screening, identity diagnostics and forensics, pre-natal DNA carrier screening, infectious disease diagnostics, oncology histopathology and diagnostics, and so on. Genetic testing involves the use of hair, blood, skin, and other samples. Depending on the suspected ailment, the sample is sent to a lab, where researchers look for specific proteins, DNA, or chromosome changes. Kits and panels are used in DNA testing to detect diseases in humans. Human blood samples are collected for DNA testing, and the tests are performed using test kits and lab equipment.

Genome Testing Market- Market Dynamics

Growing Need for DNA Testing in Various Applications

Diagnostic testing is used to identify or rule out a specific genetic or chromosomal abnormality. When physical signs and symptoms point to a problem, genetic testing is commonly used to confirm the diagnosis. Although diagnostic testing is not available for every gene or genetic condition, it can be performed prior to birth or at any time during an individual's life. A diagnostic test's results may influence decisions about medical care and disease management. DNA sequences are employed in forensic testing to identify individuals for legal purposes. This testing can be used to establish biological relationships between persons, identify victims of crime or tragedy, exclude or implicate a criminal suspect, and so on.

Genome Testing Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 22.50% from 2024 to 2032.

Based on Test Type segmentation, the diagnostic testing sector accounted for the biggest revenue share in 2023.

Based on Disease segmentation, in 2023, cancer will dominate the market.

Based on region, North America was the leading revenue generator in 2023

Genome Testing Market- Segmentation Analysis:

The Global Genome Testing Market is segmented based on Test Type, Disease, and Region.

The market is divided into seven categories based on Test Type: Carrier Testing, Predictive Testing, Diagnostic Testing, Prenatal & Newborn Testing, Nutrigenomics, Pharmacogenomics and Others. The diagnostic testing segment dominated the worldwide genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising frequency of chronic diseases in the worldwide population. According to a survey, almost 60% of the US population suffers from at least one chronic condition. Furthermore, the rapidly rising elderly population and increased need for diagnostic tests among them have propelled the segment's expansion in recent years.

The market is divided into seven categories based on Diseases: Cancer, Alzheimer's, Thalassemia, Cystic Fibrosis, Huntington's Disease, Duchenne Muscular Dystrophy, and Other Diseases. The cancer category controlled the global genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising prevalence of cancer in the global population. The rising prevalence of cancers such as breast cancer, lung cancer, bowel cancer, and womb cancer are the primary drivers of this category.

Genome Testing Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominated the global genetic testing market in terms of revenue in 2023, and its dominance is expected to continue during the forecast period. This can be due to growing consumer knowledge of the benefits of genetic testing in the general population. Furthermore, the widespread availability of self-testing kits via online websites in countries such as the United States has increased the population's use of genetic testing kits. Furthermore, the rising prevalence of chronic diseases among the majority of the population, combined with higher consumer spending on healthcare, has accelerated market expansion. The growing senior population in the United States is likely to drive the market in the coming years.

Asia Pacific is the fastest-growing market due to the vast target population in China, India, South Korea, and Japan. Furthermore, one of the primary drivers of market expansion is the growing use of modern laboratory techniques and techniques, such as DNA sequencing, for rapid examination and diagnosis of chronic and infectious ailments.

Genome Testing Market- Competitive Landscape:

In the Genome Testing Market Competitive Landscape, several companies compete to provide advanced genome testing services and products. Genentech Inc., Sorenson Genomics, LLC, Abbott Molecular, Bayer Diagnostics, and Biocartis are among the leading companies producing cutting-edge genome sequencing and analysis technology. These organizations aim to stay competitive by investing in R&D, creating strategic alliances, and introducing novel testing solutions. Understanding the competitive environment can provide useful insights into market dynamics, allowing organizations to make informed decisions in the genomic testing industry.

Recent Developments:

In January 2022, ARCHIMED Life formed a strategic agreement with Amides Holding GmbH to increase and improve access to unique diagnostic services for genetic, biochemical, and biomarker testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL GENOME TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Genentech Inc.

Sorenson Genomics, LLC

Abbott Molecular

Bayer Diagnostics

Biocartis

BioHelix

Celera Genomics

Genomic Health

HTG Molecular Diagnostics

PacBio

Others

GLOBAL GENOME TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Carrier Testing
  • Predictive Testing
  • Diagnostic Testing
  • Prenatal & Newborn Testing
  • Nutrigenomics
  • Pharmacogenomics
  • Others

GLOBAL GENOME TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Alzheimer's
  • Thalassemia
  • Cystic Fibrosis
  • Huntington's Disease
  • Duchenne Muscular Dystrophy
  • Other Diseases

GLOBAL GENOME TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genome Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genome Testing Market Snippet by Test Type
    • 2.1.2. Genome Testing Market Snippet by Disease
    • 2.1.3. Genome Testing Market Snippet by Country
    • 2.1.4. Genome Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Genome Testing Key Market Trends

  • 3.1. Genome Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genome Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genome Testing Market Opportunities
  • 3.4. Genome Testing Market Future Trends

4. Genome Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genome Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genome Testing Market Landscape

  • 6.1. Genome Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genome Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Carrier Testing
    • 7.1.3. Predictive Testing
    • 7.1.4. Diagnostic Testing
    • 7.1.5. Prenatal & Newborn Testing
    • 7.1.6. Nutrigenomics
    • 7.1.7. Pharmacogenomics
    • 7.1.8. Others

8. Genome Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Alzheimer's
    • 8.1.4. Thalassemia
    • 8.1.5. Cystic Fibrosis
    • 8.1.6. Huntington's Disease
    • 8.1.7. Duchenne Muscular Dystrophy
    • 8.1.8. Other Diseases

9. Genome Testing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Genome Testing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Genome Testing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Genome Testing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Genome Testing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Genome Testing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Genome Testing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Genentech Inc.
    • 10.2.2. Sorenson Genomics, LLC
    • 10.2.3. Abbott Molecular
    • 10.2.4. Bayer Diagnostics
    • 10.2.5. Biocartis
    • 10.2.6. BioHelix
    • 10.2.7. Celera Genomics
    • 10.2.8. Genomic Health
    • 10.2.9. HTG Molecular Diagnostics
    • 10.2.10. PacBio
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us